perampanel
Selected indexed studies
- Perampanel: Does it have broad-spectrum potential? (Epilepsia, 2019) [PMID:29953584]
- Perampanel add-on for drug-resistant focal epilepsy. (Cochrane Database Syst Rev, 2023) [PMID:37059702]
- ALSUntangled 48: Perampanel (Fycompa). (Amyotroph Lateral Scler Frontotemporal Degener, 2019) [PMID:30786786]
_Worker-drafted node — pending editorial review._
Connections
perampanel is a side effect of
Sources
- Perampanel: Does it have broad-spectrum potential? (2019) pubmed
- Perampanel add-on for drug-resistant focal epilepsy. (2023) pubmed
- ALSUntangled 48: Perampanel (Fycompa). (2019) pubmed
- Perampanel monotherapy for the treatment of epilepsy: Clinical trial and real-world evidence. (2022) pubmed
- Perampanel for amyotrophic lateral sclerosis: A systematic review and meta-analysis. (2022) pubmed
- Perampanel as precision therapy in rare genetic epilepsies. (2023) pubmed
- Perampanel and pregnancy. (2021) pubmed
- Perampanel-induced erectile dysfunction. (2024) pubmed
- Pilot Trial of Perampanel on Peritumoral Hyperexcitability in Newly Diagnosed High-grade Glioma. (2024) pubmed
- Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements. (2021) pubmed